June 25, 2026 Newswires

Study Results from Vanderbilt University Medical Center Provide New Insights into Cancer (Oncology Organization and Oncologist Networks Under Medicare Advantage Plans): Cancer

Insurance Daily News

2026 JUN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Researchers detail new data in Cancer. According to news reporting originating in Nashville, Tennessee, by NewsRx journalists, research stated, “More than half of Medicare beneficiaries are now enrolled in Medicare Advantage (MA) plans. These plans offer lower premiums and additional benefits compared with Traditional Medicare ™ but commonly restrict organization and clinician networks, potentially limiting access to specialists, including oncologists.”

The news reporters obtained a quote from the research from Vanderbilt University Medical Center, “Little is known about the use of oncology networks in MA plans. To evaluate effective oncology network breadth under MA plans based on realized health care utilization. This cross-sectional study used linked 2016-2019 Surveillance, Epidemiology, and End Results (SEER)-Medicare data to characterize effective oncology networks among beneficiaries diagnosed with 8 common cancers. Network trends were examined separately for regular MA plans and special needs plans (SNPs) within SEER counties, and network breadth was compared by metropolitan status and plan type (health maintenance organization [HMO], local or regional preferred provider organization [PPO], point-of-service [POS] plan, or other). Data were analyzed between March 1, 2025, and April 1, 2026. Effective oncology network breadth was defined at the plan-county-year level as the share of oncology organizations and oncologists accessed by MA beneficiaries relative to oncology organizations and oncologists accessed by TM beneficiaries in the same county-year, measured separately for oncology organizations, medical or surgical oncologists, and radiation oncologists and more than 1 MA-recorded visit to a National Cancer Institute (NCI)-designated comprehensive cancer center. A total of 807 580 MA beneficiaries (mean [SD] age, 70.4 [9.0] years; 420 662 males [52.1%]) were identified, representing 23 255 plan-year observations for regular MA plans and 17 716 for SNPs from 2016 through 2019. Across regular MA plans, beneficiaries accessed a mean (SD) of 12.0% (12.7%) of oncology organizations, 6.8% (9.6%) of medical or surgical oncologists, and 11.6% (13.8%) of radiation oncologists; across SNPs, beneficiaries accessed 12.4% (12.6%) of oncology organizations, 7.2% (8.6%) of medical or surgical oncologists, and 12.7% (15.5%) of radiation oncologists. MA-recorded visits to NCI-designated comprehensive cancer centers were observed in 25.7% (n = 5983 of 23255) of regular MA plans and 20.5% (n = 3624 of 17716) of SNPs. Effective oncology network breadth was narrower for HMOs; nonmetropolitan (vs metropolitan) counties and regional PPOs (vs other plan types) had lower likelihood of MA-recorded visits to NCI-designated comprehensive cancer centers. In this cross-sectional study of MA plans in SEER regions from 2016 to 2019, effective oncology organization and oncologist networks were constrained.”

According to the news reporters, the research concluded: “Restricted access to NCI-designated comprehensive cancer centers might limit access to innovative treatments and cancer outcomes, which warrants future research.”

For more information on this research see: Oncology Organization and Oncologist Networks Under Medicare Advantage Plans. JAMA Network Open, 2026;9(6). JAMA Network Open can be contacted at: Amer Medical Assoc, 330 N Wabash Ave, Ste 39300, Chicago, IL 60611-5885, USA.

Our news correspondents report that additional information may be obtained by contacting Youngmin Kwon, Dept. of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee. Additional authors for this research include Xin Hu, Qinjin Fan, Kewei Sylvia Shi, Zhiyuan Zheng, Jingxuan Zhao, Joan L. Warren, K. Robin Yabroff, Zhanji Zhang, Xuesong Han and Changchuan Jiang.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1001/jamanetworkopen.2026.18507. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.